Product NDC: | 0185-0940 |
Proprietary Name: | Cholestyramine |
Non Proprietary Name: | Cholestyramine |
Active Ingredient(s): | 4 g/9g & nbsp; Cholestyramine |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0185-0940 |
Labeler Name: | Eon Labs, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074557 |
Marketing Category: | ANDA |
Start Marketing Date: | 19960815 |
Package NDC: | 0185-0940-97 |
Package Description: | 378 g in 1 CAN (0185-0940-97) |
NDC Code | 0185-0940-97 |
Proprietary Name | Cholestyramine |
Package Description | 378 g in 1 CAN (0185-0940-97) |
Product NDC | 0185-0940 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cholestyramine |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 19960815 |
Marketing Category Name | ANDA |
Labeler Name | Eon Labs, Inc. |
Substance Name | CHOLESTYRAMINE |
Strength Number | 4 |
Strength Unit | g/9g |
Pharmaceutical Classes | Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] |